Skip to content

RISE (Rehabilitation Intervention for People With Schizophrenia in Ethiopia)

RISE (Rehabilitation Intervention for People With Schizophrenia in Ethiopia): a Cluster-randomised Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02160249
Acronym
RISE
Enrollment
166
Registered
2014-06-10
Start date
2015-09-30
Completion date
2017-05-08
Last updated
2017-05-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Schizoaffective Disorder, Schizophrenia, Schizophrenia Spectrum Disorder, Schizophreniform Disorder

Keywords

Schizophrenia, Psychotic disorders, Schizophrenia spectrum disorder (schizophrenia, schizoaffective disorder or schizophreniform disorder) using DSM-IV criteria

Brief summary

The purpose of this study is to determine whether community-based rehabilitation plus facility-based care is superior to facility-based care alone in reducing disability related to schizophrenia in rural Ethiopia.

Detailed description

This is a cluster randomised trial set in rural Ethiopia with kebeles (villages) as the unit of randomisation. 54 kebeles will be included. 27 will be randomly allocated to the intervention arm (Facility based care (FBC) + Community-based Rehabilitation (CBR)) and 27 randomly allocated to the control arm (FBC alone). The aim is to determine whether CBR + FBC is superior to FBC alone in reducing disability related to schizophrenia, measured by the WHO Disability Assessment Schedule version 2.0 (WHODAS 2.0) at 6 and 12 months.

Interventions

BEHAVIORALCommunity-based rehabilitation
OTHERFacility based care

Sponsors

Addis Ababa University
CollaboratorOTHER
London School of Hygiene and Tropical Medicine
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age ≥18 years * Diagnosis of schizophrenia spectrum disorder (schizophrenia, schizoaffective disorder or schizophreniform disorder) using (DSM-IV) criteria * Evidence of severe, enduring or disabling illness * Resident in kebele for \>6 months and no immediate plans to leave the kebele * Has a primary caregiver who is willing to participate in the study

Exclusion criteria

* No specific criteria

Design outcomes

Primary

MeasureTime frame
Disability (36-item WHODAS (World Health Organisation Disability Assessment Schedule) 2.0)12 months

Secondary

MeasureTime frameDescription
Proportion with human rights problems (chaining or restraint)- Caregiver-reported6 and 12 monthsCaregiver to report presence of human rights problems relating to patient. The outcome is the proportion chained, restrained or confined within last one month. Additional data on who perpetrated the chaining i.e. traditional healer/ family member will be collected.
Nutritional status (BMI)6 and 12 months
Serious adverse events6 and 12 months
Economic activity of caregiver6 and 12 monthsSection includes current occupation (categories), employment status (categories), typical income (specific amount). Section also includes questions adapted from the WHO-DAS 12 and 36 relating to problems doing usual work tasks (likert scale).
Caregiver burden (WHO Family Interview Schedule Impact section)6 and 12 months
Caregiver depression (PHQ9 +1)6 and 12 months
Patient medication adherence6 and 12 months
Symptom severity (Brief Psychiatric Rating Scale- Expanded version (BPRS-E))6 and 12 months
Clinical Global Impression (CGI)6 and 12 months
Relapse (Longitudinal Interval Follow up Evaluation: DSM-IV version (LIFE))6 and 12 months
Disability (36-item WHODAS 2.0)6 months
Functioning (indigenous functioning scale)6 and 12 monthsScale is currently under development. It is being designed and validated to measure functioning in people with severe mental illness in rural Ethiopia.
Economic activity of patient (employment, income and household work)6 and 12 monthsSection includes current occupation (categories), employment status (categories), typical income (specific amount). Section also includes questions adapted from the WHO-DAS 12 and 36 relating to problems doing usual work task both generally and as a result of their mental illness (likert scale)
Medication adherence (4 item Morisky Medication Adherence Scale)6 and 12 months
Engagement with facility based care6 and 12 monthsPotential mediator
Proportion with human rights problems (chaining or restraint)- self-reported6 and 12 monthsThe outcome is the proportion chained, restrained or confined within last one month. Additional data on who perpetrated the chaining i.e. traditional healer/ family member will be collected.

Other

MeasureTime frameDescription
Health service use and costs6 and 12 monthsPotential mediator
Depression (PHQ-9+1)6 and 12 monthsPotential confounder
Access/ adherence to CBR and reasons for non-adherence6 and 12 monthsPotential mediator
Social support (OSLO-3)6 and 12 monthsPotential mediator
Stigma and discrimination (WHO Family Interview Schedule Stigma section)6 and 12 months
Discrimination (DISC-12)6 and 12 monthsPotential mediator

Countries

Ethiopia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 20, 2026